Cargando…
When comparing the safety of drugs, don't forget the exposure dimension
Autor principal: | Zoccali, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387381/ https://www.ncbi.nlm.nih.gov/pubmed/37529641 http://dx.doi.org/10.1093/ckj/sfad091 |
Ejemplares similares
-
Therapy of membranous nephropathy: quo vadis?
por: Glassock, Richard J
Publicado: (2023) -
The place of cyclical therapy for the treatment of membranous nephropathy in the era of rituximab
por: Alberici, Federico, et al.
Publicado: (2023) -
Anti-CD20 should be the first-line treatment in high-risk membranous nephropathy
por: Zand, Ladan, et al.
Publicado: (2023) -
Pharmacological strategies to manage hyperkalaemia: out with the old, in with the new? Not so fast…
por: Carrero, Juan Jesus, et al.
Publicado: (2023) -
Sodium polystyrene is unsafe and should not be prescribed for the treatment of hyperkalaemia: primum non nocere!
por: Rossignol, Patrick, et al.
Publicado: (2023)